Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-05-17 @ 2:47 PM
Study NCT ID:
NCT00477594
Status:
COMPLETED
Last Update Posted:
2016-09-09
First Post:
2007-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Sponsor:
Kastle Therapeutics, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lipid Metabolism, Inborn Errors | View |
| None | Hypercholesterolemia, Autosomal Dominant | View |
| None | Hyperlipidemias | View |
| None | Metabolic Diseases | View |
| None | Hyperlipoproteinemia Type II | View |
| None | Metabolism, Inborn Errors | View |
| None | Genetic Diseases, Inborn | View |
| None | Infant, Newborn, Diseases | View |
| None | Metabolic Disorder | View |
| None | Congenital Abnormalities | View |
| None | Hypercholesterolemia | View |
| None | Hyperlipoproteinemias | View |
| None | Dyslipidemias | View |
| None | Lipid Metabolism Disorders | View |